Torrent Pharmaceuticals balance sheet

·Pharma & HealthChart ›
As of Sep 2026
Total assets
₹44,615cr+187.6% on Sep 2025
Shareholders' equity
₹18,373cr+117.5% on Sep 2025
Total debt
₹13,874cr+435.7% on Sep 2025
Cash and investments
₹2,964cr+317.5% on Sep 2025
₹ crore except per share
Tap a line for its trendH1 FY27Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Non-current assets
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
5,0664,9093,4553,2972,772
404457367281688
13.013.00.0—0.0
3,9903,990339338338
23,35224,2804,1524,5035,012
20018411180.077.0
87.083.044.032.043.0
2.03.03.03.02.0
32.044.033.037.049.0
12113080.072.094.0
710698595555544
241258268324158
34,09734,9199,3679,4509,683
Current assets
3,1823,1382,5412,2792,230
2,073866112141156
3,3983,0311,8671,8441,944
8911,117573835508
22.048.06.04.063.0
5.05.05.03.02.0
259558183201108
6,6485,6252,7463,0282,781
687629336304303
10,5179,3925,6235,6115,314
1.01.00.0—15.0
44,61544,31214,99015,06115,012
Equity
190169169169169
18,1838,2207,4226,6876,029
18,3738,3897,5916,8566,198
0.09,1960.0—0.0
18,37317,5857,5916,8566,198
Liabilities
11,62011,6511,1921,6042,496
21627616073.074.0
11,83611,9271,3521,6772,570
886765501445393
5,5175,670829656402
19.022.00.01.02.0
18,25818,3842,6822,7793,367
2,2543,1471,8342,3342,801
2,2232,3581,8202,0891,679
2,3302,042423305439
6,8077,5474,0774,7284,919
518499408400394
52512196.016831.0
134176136130103
7,9848,3434,7175,4265,447
26,24226,7277,3998,2058,814
44,61544,31214,99015,06115,012
Trade payables — MSME split
13016323.0——
2,0932,1951,797——
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

TORNTPHARM₹4,557.00

Torrent Pharmaceuticals Ltd.

· Pharma & Health
₹ CrorePeersSUNPHARMAJBCHEPHARMMANKINDZYDUSLIFEDIVISLABMAXHEALTHDRREDDYCIPLAMcap ₹1.54L Cr
View
In ₹ Crore except Per Share
As of
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Non-current Assets
+ Property, Plant & Equipment2,772.03,297.03,455.04,909.05,066.0
+ Capital Work-in-Progress688.0281.0367.0457.0404.0
+ Investment Property0.0—0.013.013.0
+ Goodwill338.0338.0339.03,990.03,990.0
+ Other Intangibles5,012.04,503.04,152.024,280.023,352.0
+ Intangibles under Development77.080.0111.0184.0200.0
+ Non-current Investments43.032.044.083.087.0
+ Long-term Loans2.03.03.03.02.0
+ Other Non-current Financial Assets49.037.033.044.032.0
Non-current Financial Assets94.072.080.0130.0121.0
+ Deferred Tax Assets544.0555.0595.0698.0710.0
+ Other Non-current Assets158.0324.0268.0258.0241.0
Total Non-current Assets9,683.09,450.09,367.034,919.034,097.0
Current Assets
+ Inventories2,230.02,279.02,541.03,138.03,182.0
+ Current Investments156.0141.0112.0866.02,073.0
+ Trade Receivables1,944.01,844.01,867.03,031.03,398.0
+ Cash & Cash Equivalents508.0835.0573.01,117.0891.0
+ Other Bank Balances63.04.06.048.022.0
+ Short-term Loans2.03.05.05.05.0
+ Other Current Financial Assets108.0201.0183.0558.0259.0
Current Financial Assets2,781.03,028.02,746.05,625.06,648.0
+ Other Current Assets303.0304.0336.0629.0687.0
Total Current Assets5,314.05,611.05,623.09,392.010,517.0
+ Assets Held for Sale15.0—0.01.01.0
Total Assets15,012.015,061.014,990.044,312.044,615.0
Equity
+ Equity Share Capital169.0169.0169.0169.0190.0
+ Other Equity / Reserves6,029.06,687.07,422.08,220.018,183.0
Equity — Owners of Parent6,198.06,856.07,591.08,389.018,373.0
+ Minority Interest0.0—0.09,196.00.0
Total Equity6,198.06,856.07,591.017,585.018,373.0
Liabilities
+ Borrowings — Non-current2,496.01,604.01,192.011,651.011,620.0
+ Other Non-current Financial Liab74.073.0160.0276.0216.0
Non-current Financial Liabilities2,570.01,677.01,352.011,927.011,836.0
+ Provisions — Non-current393.0445.0501.0765.0886.0
+ Deferred Tax Liabilities402.0656.0829.05,670.05,517.0
+ Other Non-current Liabilities2.01.00.022.019.0
Non-current Liabilities3,367.02,779.02,682.018,384.018,258.0
+ Borrowings — Current2,801.02,334.01,834.03,147.02,254.0
+ Trade Payables1,679.02,089.01,820.02,358.02,223.0
+ Other Current Financial Liab439.0305.0423.02,042.02,330.0
Current Financial Liabilities4,919.04,728.04,077.07,547.06,807.0
+ Provisions — Current394.0400.0408.0499.0518.0
+ Current Tax Liabilities31.0168.096.0121.0525.0
+ Other Current Liabilities103.0130.0136.0176.0134.0
Current Liabilities5,447.05,426.04,717.08,343.07,984.0
Total Liabilities8,814.08,205.07,399.026,727.026,242.0
Total Equity & Liabilities15,012.015,061.014,990.044,312.044,615.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current——23.0163.0130.0
+ Dues to Other Creditors — Current——1,797.02,195.02,093.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.